Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have been diagnosed with schizophrenia according to a standard diagnostic system called DSM-V
- People whose medication has remained stable for at least 4 weeks
- People whose schizophrenia mainly involves "negative symptoms" (such as reduced motivation or emotional expression), measured by specific scores on a standard assessment tool called the PANSS (confirm with trial site for exact score details)
- People (or their legal representative) who are willing to take part and have signed a consent form
- People who are fluent in French
- People who are affiliated with a French social security scheme
Who may not be able to join:
- People who have a medical reason that prevents them from receiving TMS (Transcranial Magnetic Stimulation, a type of brain stimulation), such as a metal object inside the skull, epilepsy that is not well controlled, a cochlear implant, or a pacemaker
- People who have a medical condition that is not currently stable or well managed
- People who are pregnant
- People who could become pregnant and are not using effective contraception
- People who are currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dominique Januel, Clinical research unit, EPS Ville Evrard
Phone: +33 1 43 09 32 32
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the efectiveness of rTMS on the negative symptoms of schizophrena, assessed by the SANS ( Scale Assessment Negative Symptoms).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.